⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL27958740 | 1.00 | — | — | |
| Ethylene SCHEMBL28706382 | 1.00 | — | — | |
| Ethylene SCHEMBL30131118 | 0.93 | — | — | |
| Ethylene SCHEMBL10799938 | 0.93 | — | — | |
| Ethylene SCHEMBL10799933 | 0.93 | — | — | |
| Ethylene SCHEMBL25322047 | 0.93 | — | — | |
| Ethylene SCHEMBL28625999 | 0.93 | — | — | |
| Ethylene SCHEMBL115622 | 0.93 | — | — | |
| Ethylene SCHEMBL894333 | 0.93 | — | — | |
| Ethylene SCHEMBL28812864 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092040-A1 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | PAPAIOANNOU NIKOLAOS (US) | 2026-04-02 | — | — | US | claimed |
| EP-4590663-A2 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | Takeda Pharmaceutical Company Limited (JP) | 2025-07-30 | — | — | EP | claimed |
| WO-2024064214-A2 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-03-28 | — | — | WO | claimed |
| CN-113382982-B | Preparation method of siponimod | 广东东阳光药业有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-3553054-B1 | FLUORESCENT COUMARIN COMPOUNDS AND METHOD OF SYNTHESIS THEREOF | UNIV EVORA (PT) | 2023-01-11 | — | — | EP | claimed |
| CN-113382982-A | Preparation method of siponimod | 广东东阳光药业有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-105932236-B | A kind of coating modification method of lithium ion battery electrode material | 河海大学 | 2019-03-15 | — | — | CN | claimed |
| EP-2931708-B1 | CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF | DIVERCHIM (FR) | 2017-05-10 | — | — | EP | claimed |
| US-9527798-B2 | Cyclopropylboronic compounds, preparation process thereof and use thereof | DIVERCHIM (FR) | 2016-12-27 | — | — | US | claimed |
| CN-105932236-A | Coating and modifying method for electrode material of lithium ion battery | 河海大学 | 2016-09-07 | — | — | CN | claimed |
| US-20150329566-A1 | CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF | DIVERCHIM (FR) | 2015-11-19 | — | — | US | claimed |
| EP-2931708-A2 | CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF | Diverchim (FR) | 2015-10-21 | — | — | EP | claimed |
| WO-2014091167-A2 | CYCLOPROPYLBORONIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF | DIVERCHIM (FR) | 2014-06-19 | — | — | WO | claimed |
| EP-1057831-B1 | Process for the preparation of vinyl pyrimidine derivatives | HOFFMANN LA ROCHE (CH) | 2004-09-22 | — | — | EP | claimed |
| US-20260125398-A1 | 5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS | AMGEN INC. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4727542-A2 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT DEGRADE SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A | Plexium, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092040-A1 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | PAPAIOANNOU NIKOLAOS (US) | 2026-04-02 | — | — | US | disclosed |
| US-20060100465-A1 | METHOD FOR HALOGENATING OR RADIOHALOGENATING A CHEMICAL COMPOUND | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-05-11 | — | — | US | disclosed |
| US-7041859-B1 | Method for halogenating or radiohalogenating a chemical compound | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2006-05-09 | — | — | US | disclosed |
| US-20050256127-A1 | 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation | ABBVIE INC. | 2005-11-17 | — | — | US | disclosed |